Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. As of July 29, 2026, Novartis India Limited operates as a subsidiary of Waverise Investments Limited.
Key Metrics
as of Sep 2026
Market Cap 4,066 Cr
P/E 41.60
Div Yield 1.52 %
Book Value βΉ331.00
52w High βΉ1,780.00
52w Low βΉ750.00
Face Value βΉ5.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
104.00
91.00
86.00
90.00
88.00
84.00
93.00
87.00
92.00
81.00
85.00
79.00
91.00
Expenses
69.00
70.00
64.00
66.00
60.00
60.00
67.00
69.00
68.00
70.00
65.00
62.00
73.00
Operating Profit
35.00
21.00
22.00
24.00
27.00
24.00
26.00
18.00
24.00
11.00
20.00
17.00
17.00
OPM %
34.00
23.00
26.00
26.00
31.00
29.00
28.00
21.00
26.00
14.00
23.00
21.00
19.00
Other Income
9.00
10.00
9.00
9.00
11.00
11.00
11.00
10.00
10.00
10.00
22.00
17.00
12.00
Depreciation
0.00
0.00
0.00
1.00
1.00
1.00
1.00
1.00
1.00
0.00
0.00
1.00
2.00
Interest
0.00
0.00
1.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.00
0.00
Profit before tax
43.00
30.00
30.00
33.00
37.00
34.00
35.00
28.00
34.00
21.00
41.00
32.00
28.00
Tax %
25.00
16.00
46.00
26.00
26.00
14.00
28.00
26.00
24.00
31.00
36.00
27.00
27.00
Net Profit
32.00
25.00
16.00
24.00
28.00
29.00
25.00
20.00
26.00
15.00
27.00
24.00
20.00
EPS in Rs
13.05
10.23
6.52
9.81
11.19
11.87
10.31
8.27
10.42
5.95
10.76
9.59
8.21
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
354.00 356.00 335.00 379.00 400.00 381.00 438.00 491.00 564.00 656.00 690.00 870.00
Expenses
260.00 265.00 270.00 314.00 373.00 355.00 426.00 478.00 570.00 631.00 656.00 874.00
Operating Profit
94.00 91.00 65.00 65.00 27.00 27.00 12.00 12.00 -6.00 25.00 34.00 -4.00
OPM %
27.00 26.00 19.00 17.00 7.00 7.00 2.80 2.50 -1.10 3.80 5.00 -0.40
Other Income
39.00 42.00 62.00 58.00 -17.00 33.00 36.00 78.00 172.00 71.00 207.00 101.00
Interest
1.00 1.00 1.00 2.00 5.00 8.00 6.00 2.00 6.00 1.00 0.00 0.00
Depreciation
2.00 2.00 3.00 6.00 10.00 12.00 13.00 3.00 3.00 4.00 3.00 4.00
Profit before tax
130.00 130.00 123.00 115.00 -4.00 40.00 29.00 86.00 158.00 92.00 237.00 93.00
Tax %
28.00 23.00 31.00 10.00 -3.00 48.00 65.00 40.00 50.00 38.00 16.00 15.00
Net Profit
93.00 101.00 85.00 103.00 -4.00 21.00 10.00 52.00 78.00 57.00 198.00 79.00
EPS in Rs
37.74 40.87 34.50 41.86 -1.51 8.46 4.08 20.97 31.74 20.33 62.04 24.75
Dividend Payout %
66.00 61.00 72.00 113.00 -663.00 118.00 245.00 48.00 32.00 49.00 16.00 40.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
12.00 12.00 12.00 12.00 12.00 12.00 12.00 12.00 12.00 14.00 16.00 16.00
Reserves
805.00 773.00 732.00 763.00 679.00 699.00 708.00 747.00 721.00 906.00 1,178.00 986.00
Borrowings
3.00 5.00 7.00 22.00 24.00 62.00 68.00 0.00 0.00 0.00 0.00 0.00
Other Liabilities
157.00 158.00 173.00 186.00 242.00 229.00 289.00 223.00 377.00 230.00 239.00 244.00
Total Liabilities
978.00 948.00 925.00 983.00 958.00 1,002.00 1,078.00 982.00 1,111.00 1,150.00 1,433.00 1,246.00
Fixed Assets
3.00 5.00 7.00 19.00 24.00 64.00 76.00 15.00 5.00 6.00 6.00 8.00
CWIP
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
975.00 943.00 918.00 964.00 934.00 938.00 1,001.00 967.00 1,106.00 1,144.00 1,426.00 1,238.00
Total Assets
978.00 948.00 925.00 983.00 958.00 1,002.00 1,078.00 982.00 1,111.00 1,150.00 1,433.00 1,246.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
47.00 75.00 113.00 45.00 39.00 -69.00 -23.00 -194.00 161.00 -41.00 57.00 -60.00
Cash from Investing Activity
18.00 -3.00 33.00 -153.00 87.00 95.00 56.00 274.00 69.00 424.00 -630.00 719.00
Cash from Financing Activity
-64.00 -64.00 -121.00 -30.00 -36.00 -37.00 -41.00 -30.00 -268.00 -332.00 -39.00 -38.00
Net Cash Flow
0.00 7.00 26.00 -139.00 90.00 -11.00 -9.00 50.00 -38.00 51.00 -612.00 622.00
Free Cash Flow
46.00 75.00 113.00 45.00 38.00 -69.00 -24.00 -208.00 160.00 -44.00 54.00 -64.00
CFO/OP %
87.00 99.00 115.00 65.00 210.00 -127.00 124.00 -1,210.00 -3,503.00 13.00 398.00 601.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
38.00 41.00 45.00 35.00 41.00 37.00 31.00 34.00 28.00 23.00 27.00 35.00
Inventory Days
98.00 74.00 82.00 99.00 117.00 119.00 117.00 111.00 84.00 104.00 92.00 103.00
Days Payable
101.00 93.00 112.00 108.00 148.00 137.00 145.00 168.00 158.00 87.00 89.00 98.00
Cash Conversion Cycle
36.00 22.00 15.00 26.00 10.00 19.00 3.00 -23.00 -45.00 40.00 30.00 40.00
Working Capital Days
-46.00 -45.00 -59.00 -37.00 -23.00 62.00 -1.00 7.00 -99.00 -14.00 -35.00 6.00
ROCE %
16.00 17.00 16.00 15.00 6.00 6.00 5.00 12.00 17.00 9.00 22.00 9.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jul 2026
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Promoters
70.68
70.68
70.68
70.68
70.68
70.68
70.68
70.68
70.68
70.68
70.68
70.68
FIIs
0.15
0.16
0.17
0.19
0.19
0.19
0.19
0.19
0.19
0.19
0.19
0.19
DIIs
1.39
1.35
0.53
0.63
0.53
0.53
0.53
0.53
0.52
0.52
0.52
0.52
Public
27.79
27.81
28.60
28.50
28.61
28.60
28.61
28.60
28.61
28.60
28.61
28.60
No. of Shareholders
36,706
36,502
38,116
39,468
39,353
39,040
39,133
38,926
39,596
39,265
41,239
43,128
Corporate Actions
26 records
Back to all stocks